Our Company
Our Company
Our Strategy
Governance
Governance
Board of Directors
Executive Committee
Specialist Committees
Our Legacy
Social Impact
Social Impact
Access to Healthcare
Innovation for Vulnerable Communities
Environmental Sustainability and Resilience
Diversity, Equity, and Inclusion In and Beyond the Workplace
Code of Conduct and Responsible Business
Our Science
Our Science
Our Pipeline
R&D Focus Areas
R&D Focus Areas
Immunology R&D
Neurology R&D
Oncology R&D
Rare Blood Disorders R&D
Rare Diseases R&D
Vaccines R&D
Artificial Intelligence in R&D
Technology Platforms
Clinical Trials & Results
Clinical Trials & Results
Find a Clinical Trial
Clinical Study Results
Investigator Sponsored Studies
Diversity in Clinical Trials
Scientific Collaboration
Scientific Collaboration
Scientific Collaboration in North America
Scientific Collaboration in Europe
Scientific Collaboration in China
Digital
Manufacturing and Supply
Your Health
Your Health
Vaccines & Infectious Diseases
Vaccines & Infectious Diseases
Influenza
Meningococcal Meningitis
E. coli sepsis
Respiratory Syncytial Virus (RSV)
Production
Why Vaccines Matter
Medicines
Medicines
Immunology
Neurology
Oncology
Rare Blood Disorders
Rare Diseases
Cardiovascular Diseases
Diabetes
Consumer Healthcare
Consumer Healthcare
Sustainability at Sanofi Consumer Healthcare
Allergy
Cough, Cold & Flu
Digestive Wellness
Pain Care
Physical & Mental Wellness
Integrated Patient Engagement
Healthcare Professionals Support
Healthcare Professionals Support
Managed Access Programs (MAPs)
Pre-Registration Import Licenses
Post Trial Access (PTA)
Partnering
Partnering
Partnering Focus Areas
Partnering Focus Areas
China
Digital
General Medicines
Immunology
Neuroscience
Oncology
Out-Licensing
Rare Disease
Technology Platforms
Vaccines
Meet the Partnering Team
Contact Business Development Team
Media
Media
Stories
Press Releases
Contacts
Investors
Investors
News
Results and Presentations
Results and Presentations
Results
Presentations
Conferences
Environment, Social, Governance
Environment, Social, Governance
Our Latest ESG news
ESG quarterly update
Private Shareholders
Shares and ADRs
Shares and ADRs
Sanofi stock chart
Dividend
ADRs
Shares, Structure & Vote
Analyst Coverage
Vara consensus
Share repurchases
Bonds
Contacts
Careers
Paris 2024
Paris 2024
Meet Team Sanofi
Follow the Paris 2024 Olympic and Paralympic Torches Relays
Global
Homepage
Our Company
Governance
Regulated Agreements
Regulated Agreements
Pursuant to Article L. 225-40-2 of the French Commercial Code, the Related-party agreements entered into by Sanofi are presented below.
October 30, 2019 - Conclusion of agreements with Dassault Systèmes
Governance